Peter Gaede (MD, DMSc) is Professor of Endocrinology at the University of Southern Denmark, Odense and Chief Physician at the Department of Cardiology and Endocrinology, Slagelse Naestved Ringsted Hospital, Denmark.
He graduated from the University of Copenhagen in 1990 and became a specialist in internal medicine and endocrinology in 2006 and 2010, respectively. He wrote his medical thesis on the importance of intensified multiple risk-factor intervention in patients with type 2 diabetes under the supervision of Professor Oluf Pedersen at the Steno Diabetes Center in Copenhagen, Denmark. For that he was appointed Doctor of Medical Science (DMSc) in 2006.
He was the daily leader of the Steno-2 study, which demonstrated that intensified risk-factor intervention in type 2 diabetes could cut the risk of any diabetes-related complication by 50% and prolong the median life span by almost eight years. Results from the trial have had tremendous impact on recent guidelines for treatment of type 2 diabetes worldwide.
Peter’s principal research activities are focused on type 2 diabetes, cardiovascular disease, kidney disease and therapeutics, as well as economic aspects of treatment and specific interventions. He has played a major role in setting up the magnetic resonance imaging (MRI) of the heart centre at Slagelse Naestved Ringsted Hospital.
Currently, he is the main supervisor for four PhD students and co-supervisor for three others. So far, three students have achieved their PhD degrees under his supervision.
He is a former board member of the Danish Society of Endocrinology and served as a board member the Postgraduate Education Committee under the European Association for the Study of Diabetes (EASD). He has given more than 100 lectures and workshops on diabetes treatment in more than 50 countries.
He has published over 80 articles in peer-reviewed journals, with over 11,000 citations.
Duality of Interest: None declared.
Date: Summer 2023